niacinamide and olaparib

niacinamide has been researched along with olaparib in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lehtiƶ, L; Narwal, M; Venkannagari, H1
Ellis, LM; Harris, AL; Jayson, GC; Kerbel, R1
Baks-Te Bulte, L; Brundel, BJJM; de Groot, NMS; de Vries, AAF; Henning, RH; Hoogstra-Berends, F; Hu, X; Lanters, EAH; Li, J; Liu, J; Malik, NU; Pijnappels, DA; Tolouee, M; van Marion, DMS; van Roon, AM; Wiersma, M; Zhang, D1

Reviews

1 review(s) available for niacinamide and olaparib

ArticleYear
Antiangiogenic therapy in oncology: current status and future directions.
    Lancet (London, England), 2016, Jul-30, Volume: 388, Issue:10043

    Topics: Angiogenesis Inhibitors; Angiopoietin-1; Biomarkers, Tumor; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Molecular Targeted Therapy; Neoplasms; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Protein Kinase Inhibitors; Quinazolines; Quinolines; Receptor, TIE-2; Signal Transduction; Sorafenib; Vascular Endothelial Growth Factor A

2016

Other Studies

2 other study(ies) available for niacinamide and olaparib

ArticleYear
Structural basis of selective inhibition of human tankyrases.
    Journal of medicinal chemistry, 2012, Feb-09, Volume: 55, Issue:3

    Topics: Catalytic Domain; Crystallography, X-Ray; Enzyme Assays; Humans; Models, Molecular; Niacinamide; Phthalazines; Piperazines; Protein Binding; Protein Conformation; Quinolines; Structure-Activity Relationship; Tankyrases

2012
DNA damage-induced PARP1 activation confers cardiomyocyte dysfunction through NAD
    Nature communications, 2019, 03-21, Volume: 10, Issue:1

    Topics: Animals; Atrial Fibrillation; Benzimidazoles; Cells, Cultured; DNA Damage; Drosophila melanogaster; Enzyme Activation; Heart Atria; Humans; Larva; Mice; Models, Cardiovascular; Myocardial Contraction; Myocytes, Cardiac; NAD; Niacinamide; Oxidative Stress; Pacemaker, Artificial; Phthalazines; Piperazines; Poly (ADP-Ribose) Polymerase-1; Pupa; Rats; Rats, Wistar

2019